跳至主要内容
临床试验/NCT01432522
NCT01432522已完成不适用

Comparison of Absorption of Epinephrine Into the Circulation After Epinephrine Intranasal Spray Administration and After Intramuscular Injection

Siriraj Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Composite of Pharmacokinetics of epinephrine

研究概览

简要总结

This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.

详细描述

Patients are reluctant to use Epipen® on emergency basis, perhaps because of improperly training, hesitancy and fear of needle. Other route of administration of epinephrine (EPI) may be more benefit such as intranasal route.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy subjects
  • 18-30 years-old

排除标准

  • Subjected who use current medication that interfere with result of plasma epinephrine level such as pseudoephedrine

研究组 & 干预措施

epinephrine IN, epinephrine IM, saline IN

Experimental
  1. Intranasal saline
  2. Intramuscular epinephrine
  3. Intranasal epinephrine

干预措施: Epinephrine (Drug)

结局指标

主要结局

Composite of Pharmacokinetics of epinephrine

时间窗: predose, 5 , 10, 15, 20, 30, 45, 60, 90, 120, 180 minutes post-dose

Cmax, Area Under Curve, Tmax of epinephrine compare between 0.3 mg intramuscular and 5 mg intranasal route

次要结局

  • Numbers of participants with adverse events as a measure of safety and tolerability(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pakit Vichyanond, MD

Professor of Pediatrics

Siriraj Hospital

研究点 (1)

Loading locations...

相似试验